Picture of ScandiDos AB logo

SDOS — ScandiDos AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: ScandiDos to start sales of Delta4 Phantom+ in US following FDA approval

Aug 20 (Reuters) - ScandiDos AB  SDOS.ST : 
    * Says US FDA (Food And Drug Association) has approved Delta4 Phantom+ and therefore can 
marketing and sales begin in USA 
 
     
Source text: http://bit.ly/1Jk0kwI 
     
Further company coverage:  SDOS.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on ScandiDos AB

See all news